FDA Adverse Event Other Summary report: N

ADVIA CENTAUR CP ESTRADIOL-6 III ASSAY

MDR report key: 1707039 · Received May 26, 2010

Report

Report Number
1219913-2010-00059
Event Type
Other
Date Received
May 26, 2010
Date of Event
May 11, 2010
Report Date
May 13, 2010
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
CHP
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE SIEMENS FIELD APPLICATION SPECIALIST PERFORMED SERIAL DILUTIONS AT THE CUSTOMER SITE AND CONFIRMED THAT THE FINAL RESULT RELEASED TO THE CLINIC WAS APPROPRIATE. THE PREVIOUS RESULT FROM THE DAY BEFORE WAS PROCESSED NORMALLY AND HAD YIELDED THE APPROPRIATE FLAGS AND SUBSEQUENT DILUTIONS. NO ERRORS WERE REPORTED BY THE CUSTOMER FOR THE INSTRUMENT. THE CAUSE FOR THE DISCORDANT ESTRADIOL-6 III RESULT IS UNKNOWN. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 1

DISCORDANT ADVIA CENTAUR CP ESTRADIOL-6 III ASSAY RESULTS WERE OBTAINED ON A PATIENT SAMPLE. THE NEAT RESULT FOR ESTRADIOL-6 III DID NOT MATCH THE 1:5 AND THE 1:10 DILUTED RESULTS. THE NEAT RESULT WAS REPORTED TO THE REFERRING CLINIC. THE REPORT WAS THEN AMENDED AND THE 1:10 DILUTION RESULT WAS RELEASED. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ESTRADIOL-6 III RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR CP ESTRADIOL-6 III ASSAY E2-6 III IMMUNOASSAY CHP SIEMENS HEALTHCARE DIAGNOSTICS INC. NA 131

Patients

Seq Age Sex Outcome Treatment
1 25 YR